C-Reactive Protein, Interleukin-6, and Vascular Recurrence According to Stroke Subtype.
John Joseph McCabeCathal D WalshSarah GoreyKatie HarrisPablo HervellaRamon Iglesias-ReyChristina JernLinxin LiNobukazu MiyamotoJoan MontanerAnnie PedersenFrancisco F PurroyPeter M RothwellCathie L M SudlowYuji UenoMikel VicenteWilliam N WhiteleyMark WoodwardPeter J KellyPublished in: Neurology (2023)
Our data provide new evidence for the selection of patients in future RCTs of anti-inflammatory therapy in stroke due to large artery atherosclerosis, small vessel occlusion, and undetermined etiology according to inflammatory marker profile.
Keyphrases
- atrial fibrillation
- end stage renal disease
- anti inflammatory
- ejection fraction
- newly diagnosed
- prognostic factors
- oxidative stress
- peritoneal dialysis
- type diabetes
- stem cells
- mesenchymal stem cells
- current status
- patient reported outcomes
- cerebral ischemia
- patient reported
- blood brain barrier
- smoking cessation
- replacement therapy